{"name":"Hemogenyx Pharmaceuticals LLC","slug":"hemogenyx-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxORHQtY0UxYV9pa0lsVmFVU2pQMUUzcWk1X2RYZkZPWFltNnVBUGtMVXJ4WGNlMER2YTJabnJucTdQanZ3bUZ4UjVKdldrNjEwMERGSTdtNnVyN21HLWh1S3VFcVMwdmNQTVVsd2ZiYndPVXZRZ1VHbV9QYm9rNjE2ZC1FMlZBZDJoNWtEeV9MSnhKMFBDMlhwb0ljcXVkQ2hPd1VtVGUzV2xfcWcxMDlXQl9aQkp0VS1VUlI3RXI3MHVWWHdoY3dyRmJwMGdoNmN5bkYyNXliS0E1LXc1a1dYeGpCSQ?oc=5","date":"2026-03-31","type":"trial","source":"ACCESS Newswire","summary":"Hemogenyx Pharmaceuticals PLC Announces Tech Transfer Completion and Clinical Trial Update - ACCESS Newswire","headline":"Hemogenyx Pharmaceuticals PLC Announces Tech Transfer Completion and Clinical Trial Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQdkxzc2dubFhiZ3dnNDd2S2laOGdZMnVaQzJfVTlOdmxibzVYNVR1OGprVzNkSTRlRFNPSjdGQ1EtUERXOWo2Vks0cnV6YUllTTJWMmYzUTlsMU93cXBJeEFaX0pJaUZ5cmdybXZVa2JSNTItcUpNckl3LWk5b215cnpwWVlCQ3dBNDR2Yjl5bVc1aTVUSUlQMEp4eVhiemMxaHhUUkw2ZmxaV0hQNF9LZVcxRGpmYkc0Zi1tX2V6aGVWYW13aUE?oc=5","date":"2026-02-10","type":"pipeline","source":"TradingView","summary":"REG - Hemogenyx Pharma Plc - Issue of Equity - Correction - TradingView","headline":"REG - Hemogenyx Pharma Plc - Issue of Equity - Correction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQLXZQWjhDQTlrV2NNWUh6VVBBUFFHR0g1LW1CVU1iZm9yclJhRkE1WXpvOEViVDhJOVVkLXZFaW5Wdlp2T3E4RjB3aTVScUV0eUNJUjktdF9KdWpkdDRFT2IxWHZpcE5EVmcwMjJnd2k2aXBIWmFGaTBGNWhvTnV6Rmk0SGIwS09sUnFESlZvRGlYV01FUW9lU2dBa2xmdUpiaTg1WUl3OGtHNzRKRFpoaVdaRDByX3FqaHc?oc=5","date":"2025-12-22","type":"pipeline","source":"Stock Titan","summary":"London biotech lines up Jan. 6 listing for fresh batch of shares - Stock Titan","headline":"London biotech lines up Jan. 6 listing for fresh batch of shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNWFl6T1hDbnFJMnN2Y2k5U0pVVHpEZnU5QU0tWGhoYXBCVkhkU1A5U2hfZVlieDVLNDhOS1FlTlFQODRUajI0dkM0VmJzZTFXdVZvZVhCcFM0aDVqMHlSYmJ0eVZjZ1RlV01tNnc2bnZfOWZwaWF1WmRQWDFwWm4yMzF1d3F0SkJOVmlINWdBd3dMUVZnRTRHOGdn?oc=5","date":"2025-12-18","type":"pipeline","source":"Stock Titan","summary":"Biotech Hemogenyx adds new shares, reshaping who holds voting power - Stock Titan","headline":"Biotech Hemogenyx adds new shares, reshaping who holds voting power","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOTHdqcFBRcWVqVUY4bmN3VHRPUFJzVTA1NVljMW9OM0pnLTdtcXRPc3lfSmM2OS1ycWZtbUhUWnVtMWNvWGFjVWlwNVpmUzlNSW9vVFNqdmdTRTUzak5lVHMxQXhGQmI2YS1aUHlYTnE0S2R5d2Y3dVIyVzYycHg4ZThaMDY5YzhzVDl0YlFtM3kzemFvaF9YRjU2Q2VtblRTRGduX1AzcGNnTnlwLXpVUjBzVjUtUDNEbVo5UFhpTkE2UHBuQjl1X08yY3gxeUJGeXNBeW5qeGtVbmtuMlJpSm9iUWE?oc=5","date":"2025-10-29","type":"trial","source":"ACCESS Newswire","summary":"Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards - ACCESS Newswire","headline":"Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxOYUZ2YTFuMEluVzFfaERBTjNrRTQ5TThUM243RkFFblBzdFZ4NVJNUU8ybDJrZlpjbWo2WmJCa3BWTXBscWVSUmt2eTZmZTU1S0N4WTFHTnFENzU2NDNfVUk5em9KNWRXY3dKM0tlWExVUDVkNzZOQTFfZjR4U18xWkYxZTEtOUMzV1kwNFN0V3M0X1RyMWZlek01VkwwZVAzSXp1OGZVYlJOMHE5cGx1c3pWclN5YVQ2dXJodUJYTTBpTzRBcFkyelVKVTBSSHpNWW52d24yRV9mdk5vN25rQjdJWkc5ZkFqV0d0ZnlyUDFGZW5vVVFUelpYMHhuSFBudEloY0tHdTFXbzVkWnRSTW1MUzl1NHhWcE9ldTFmODhEWGw3T0FXeDVDTk9fTXZWX0htMzNVSzRrVDNDVWtSYnRoM3JrMVVrR05hYU1mN1ppMG0xeDhOOGdWYw?oc=5","date":"2025-09-08","type":"deal","source":"PR Newswire","summary":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia - PR Newswire","headline":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOZFdnNWgtbVJ5UWVETGlyWDBMMjhQZmgwZWZGV0JqaVRiX1REWW52T3M1ZmdhNk9aeHBKR1hsS3hnaHQxRFZDVXlXR1hvUFNMWVJlYzhqSlpOa2g5VzNrbnVXNlIzbm1HODdtUk1Iay1NWnJFSTNFYmVheUpHc25fNGJybGlfdEpzOVliNVhqUk5BalFaRDNWd3pIc2NfWkhTLVRELUxfVlBZVmMxVVRyRHRPX3lHRmpqS0pmOXR1NXpBOWpyVHpNS2VtNTRGVkMtZlZPRElfZC0wU3RlcHJwOTFIR0Q?oc=5","date":"2024-12-09","type":"pipeline","source":"ACCESS Newswire","summary":"Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN - ACCESS Newswire","headline":"Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPelIwUmR0NVo1a1FKUEJVZUdCNUJjelBSWWdmZm1mUmIyeUJjVWctdHQzVXNZYTdMMnJNXy1CT3lmVEF4UUlLdk10d0F3VGNNdmVRc2c1aFN3bWtfYWdQaWR4Y2dJN19mYUNULU9xcmNCMXdRMWd5bzZPcnEzM09qcDkyYl9vVnF2ZXhNVzBtblpwOUd1NzJKYV91YmRnVWkxaW9aODZB?oc=5","date":"2024-10-02","type":"deal","source":"Share Talk","summary":"Hemogenyx Pharma Plc (LON:HEMO) Strategic Investment from Prevail Partners, LLC - Share Talk","headline":"Hemogenyx Pharma Plc (LON:HEMO) Strategic Investment from Prevail Partners, LLC","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}